Sam Dagogo‐Jack

2.8k total citations · 1 hit paper
40 papers, 1.8k citations indexed

About

Sam Dagogo‐Jack is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Sam Dagogo‐Jack has authored 40 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Endocrinology, Diabetes and Metabolism, 18 papers in Molecular Biology and 7 papers in Surgery. Recurrent topics in Sam Dagogo‐Jack's work include Diabetes, Cardiovascular Risks, and Lipoproteins (16 papers), Diabetes Treatment and Management (15 papers) and Diabetes Management and Research (13 papers). Sam Dagogo‐Jack is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (16 papers), Diabetes Treatment and Management (15 papers) and Diabetes Management and Research (13 papers). Sam Dagogo‐Jack collaborates with scholars based in United States, Sweden and United Kingdom. Sam Dagogo‐Jack's co-authors include Leigh Perreault, Justin B. Echouffo‐Tcheugui, Linong Ji, Jill P. Crandall, Yong Ma, Steven G. Terra, David S. Schade, Sarah Fowler, Wilfred Y. Fujimoto and Elizabeth Barrett‐Connor and has published in prestigious journals such as JAMA, Circulation and PLoS ONE.

In The Last Decade

Sam Dagogo‐Jack

40 papers receiving 1.8k citations

Hit Papers

Diagnosis and Management of Prediabetes 2023 2026 2024 2025 2023 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sam Dagogo‐Jack United States 15 1.2k 537 411 351 243 40 1.8k
Kevin M. Pantalone United States 22 1.3k 1.0× 402 0.7× 450 1.1× 253 0.7× 164 0.7× 100 2.0k
Changyu Pan China 27 1.7k 1.4× 565 1.1× 334 0.8× 240 0.7× 299 1.2× 95 2.4k
György Jermendy Hungary 26 1.1k 0.9× 471 0.9× 391 1.0× 353 1.0× 229 0.9× 151 2.1k
Fernando Gerchman Brazil 28 688 0.6× 352 0.7× 296 0.7× 397 1.1× 283 1.2× 83 1.9k
Kee‐Ho Song South Korea 23 929 0.7× 420 0.8× 441 1.1× 410 1.2× 248 1.0× 70 1.9k
Rüdiger Landgraf Germany 20 1.3k 1.0× 291 0.5× 454 1.1× 330 0.9× 248 1.0× 101 2.2k
Chul Sik Kim South Korea 25 661 0.5× 476 0.9× 289 0.7× 216 0.6× 256 1.1× 97 1.6k
Annaswamy Raji United States 18 994 0.8× 409 0.8× 277 0.7× 339 1.0× 418 1.7× 34 1.7k
José León Spain 11 1.6k 1.3× 331 0.6× 530 1.3× 269 0.8× 184 0.8× 22 2.2k
Gregory Fulcher Australia 26 1.5k 1.2× 403 0.8× 641 1.6× 340 1.0× 260 1.1× 74 2.3k

Countries citing papers authored by Sam Dagogo‐Jack

Since Specialization
Citations

This map shows the geographic impact of Sam Dagogo‐Jack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sam Dagogo‐Jack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sam Dagogo‐Jack more than expected).

Fields of papers citing papers by Sam Dagogo‐Jack

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sam Dagogo‐Jack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sam Dagogo‐Jack. The network helps show where Sam Dagogo‐Jack may publish in the future.

Co-authorship network of co-authors of Sam Dagogo‐Jack

This figure shows the co-authorship network connecting the top 25 collaborators of Sam Dagogo‐Jack. A scholar is included among the top collaborators of Sam Dagogo‐Jack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sam Dagogo‐Jack. Sam Dagogo‐Jack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morales, Javier, Sam Dagogo‐Jack, Vivian Fonseca, Joshua J. Neumiller, & Sylvia E. Rosas. (2023). Perspectives on Chronic Kidney Disease With Type 2 Diabetes and Risk Management: Practical Viewpoints and a Paradigm Shift Using a Pillar Approach. Clinical Diabetes. 41(4). 553–566. 9 indexed citations
2.
Cai, Xiaoling, Chu Lin, Wenjia Yang, Sam Dagogo‐Jack, & Linong Ji. (2021). Cardiovascular outcomes of antidiabetes medications by race/ethnicity: A systematic review and meta-analysis. Journal of Diabetes and its Complications. 35(9). 107980–107980. 3 indexed citations
4.
Echouffo‐Tcheugui, Justin B., Arnaud D. Kazé, Gregg C. Fonarow, & Sam Dagogo‐Jack. (2021). Severe Hypoglycemia and Incident Heart Failure Among Adults With Type 2 Diabetes. The Journal of Clinical Endocrinology & Metabolism. 107(3). e955–e962. 16 indexed citations
5.
Cosentino, Francesco, Christopher P. Cannon, David Z.I. Cherney, et al.. (2020). Efficacy of Ertugliflozin on Heart Failure–Related Events in Patients With Type 2 Diabetes Mellitus and Established Atherosclerotic Cardiovascular Disease. Circulation. 142(23). 2205–2215. 175 indexed citations
7.
Mandal, Nawajes, et al.. (2020). Role of ceramides in the pathogenesis of diabetes mellitus and its complications. Journal of Diabetes and its Complications. 35(2). 107734–107734. 67 indexed citations
8.
Dagogo‐Jack, Sam, et al.. (2020). Trajectories of Body Weight and Fat Mass in Relation to Incident Prediabetes in a Biracial Cohort of Free-Living Adults. Journal of the Endocrine Society. 5(2). bvaa164–bvaa164. 9 indexed citations
9.
Agbim, Uchenna, Rotonya M. Carr, Octavia Pickett‐Blakely, & Sam Dagogo‐Jack. (2019). Ethnic Disparities in Adiposity: Focus on Non-alcoholic Fatty Liver Disease, Visceral, and Generalized Obesity. Current Obesity Reports. 8(3). 243–254. 43 indexed citations
10.
Dagogo‐Jack, Sam, et al.. (2018). Prediabetes and Cardiovascular Disease. Endocrinology and Metabolism Clinics of North America. 47(1). 33–50. 189 indexed citations
11.
13.
Cannon, Christopher P., Darren K. McGuire, Richard E. Pratley, et al.. (2018). Design and baseline characteristics of the eValuation of ERTugliflozin effIcacy and Safety CardioVascular outcomes trial (VERTIS-CV). American Heart Journal. 206. 11–23. 160 indexed citations
14.
Owei, Ibiye, et al.. (2017). Relationships between blood pressure and blood glucose among offspring of parents with type 2 diabetes: Prediction of incident dysglycemia in a biracial cohort. Journal of Diabetes and its Complications. 31(11). 1580–1586. 8 indexed citations
15.
Ibebuogu, Uzoma N., Oluwaseyi Bolorunduro, Smith Giri, et al.. (2015). Bivalirudin Versus Heparin Plus Glycoprotein IIb/IIIa Inhibitors in Patients with Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials. American Journal of Cardiovascular Drugs. 15(4). 275–285. 7 indexed citations
16.
Dagogo‐Jack, Sam. (2014). Leptin. CINECA IRIS Institutial research information system (University of Pisa). 9 indexed citations
17.
Sullivan, Shannon D., Kathleen A. Jablonski, José C. Florez, et al.. (2013). Genetic Risk of Progression to Type 2 Diabetes and Response to Intensive Lifestyle or Metformin in Prediabetic Women With and Without a History of Gestational Diabetes Mellitus. Diabetes Care. 37(4). 909–911. 15 indexed citations
18.
McCaffery, Jeanne M., Kathleen A. Jablonski, Paul W. Franks, et al.. (2011). TCF7L2 Polymorphism, Weight Loss and Proinsulin∶Insulin Ratio in the Diabetes Prevention Program. PLoS ONE. 6(7). e21518–e21518. 19 indexed citations
19.
Crandall, Jill P., David S. Schade, Yong Ma, et al.. (2006). The Influence of Age on the Effects of Lifestyle Modification and Metformin in Prevention of Diabetes. The Journals of Gerontology Series A. 61(10). 1075–1081. 192 indexed citations
20.
Dagogo‐Jack, Sam. (1986). Epidermal Growth Factor EGF in human saliva: Effect of age, sex, race, pregnancy and sialagogue. Scandinavian Journal of Gastroenterology. 21(sup124). 47–54. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026